Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.
Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.
The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.
Publications found:
67,960
Sort by:
Alzheimer's disease (AD) - Pipeline Insight, 2020
US$ 3,000.00
This report can be delivered to the clients within 5 Business Days DelveInsight’s, “Alzheimer’s Disease (AD) – Pipeline Insight, 2020,” report provides comprehensive insights about 100+ companies an...
November 2020
130 pages
Angioimmunoblastic T-cell lymphoma – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Angioimmunoblastic T-cell lymphoma – Pipeline Insight, 2020,” report provides comprehensive insights about 10+ compani...
November 2020
40 pages
Arteriovenous fistula (AV) – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Arteriovenous fistula (AV) – Pipeline Insight, 2020,” report provides comprehensive insights about 5+ companies and 5+...
November 2020
40 pages
ATTR Amyloidosis – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “ATTR Amyloidosis – Pipeline Insight, 2020,” report provides comprehensive insights about 8+ companies and 8+ pipeline...
November 2020
40 pages
Axial Spondyloarthritis (axSpA) - Pipeline Insight - 2020
US$ 2,000.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Axial Spondyloarthritis – Pipeline Insight, 2020,” report provides comprehensive insights about 30+ companies and 30+...
November 2020
60 pages
Bardet-Biedl Syndrome – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Bardet-Biedl Syndrome – Pipeline Insight, 2020,” report provides comprehensive insights about 1+ companies and 1+ pipe...
November 2020
40 pages
Basal Cell Nevus Syndrome (BCNS) – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Basal Cell Nevus Syndrome (BCNS) – Pipeline Insight, 2020,” report provides comprehensive insights about 5+ companies...
November 2020
40 pages
Cancer Therapy Related Diarrhea – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Cancer Therapy Related Diarrhea – Pipeline Insight, 2020,” report provides comprehensive insights about 2+ companies a...
November 2020
40 pages
Candidemia - Pipeline Insight - 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Candidemia – Pipeline Insight, 2020,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs...
November 2020
40 pages
Cardiogenic Shock - Pipeline Insight - 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Cardiogenic Shock – Pipeline Insight, 2020,” report provides comprehensive insights about 3+ companies and 3+ pipeline...
November 2020
40 pages
Castleman Disease - Pipeline Insight - 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Castleman Disease– Pipeline Insight, 2020,” report provides comprehensive insights about 3+ companies and 3+ pipeline...
November 2020
40 pages
Castrate Resistant Prostrate Cancer– Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Castrate Resistant Prostrate Cancer– Pipeline Insight, 2020,” report provides comprehensive insights about 5+ companie...
November 2020
40 pages
Cataplexy – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Cataplexy – Pipeline Insight, 2020,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs i...
November 2020
40 pages
Central Precocious Puberty - Pipeline Insight - 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Central Precocious Puberty – Pipeline Insight, 2020,” report provides comprehensive insights about 3+ companies and 3+...
November 2020
40 pages
Pulmonary alveolar proteinosis – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Pulmonary alveolar proteinosis – Pipeline Insight, 2020,” report provides comprehensive insights about 2+ companies an...
November 2020
40 pages
Medical Imaging Reagents Market by Class (Contrast Reagents, Optical Reagents, and Nuclear Reagents), Technology (Nanoparticles, Fluorescent Dyes & Probes, Radiopharmaceuticals, Fluorescent Proteins, and Quantum Dots) and Application (Diagnostics, Drug Discovery & Development, and Educational Research): Global Opportunity Analysis and Industry Forecast, 2019–2027
US$ 5,769.00
... , registering a CAGR of 8.0% from 2017 to 2023. The global medical imaging reagents market is driven by rise in cases of chronic diseases such as cancer ... regulations restrict this growth in developing regions. The global medical imaging reagents market is segmented based on class, technology, application, and ...
October 2020
231 pages
Internal Trauma Fixation Device Market by Product (Closure Devices and Bone Cement), Material (Stainless Steel, Nitinol, Titanium, Tritium, and Polyether Ether Ketone), and End User (Hospitals, Orthopedic Surgical Centers, Trauma Centers, and Ambulatory Surgery): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,769.00
... of diseases such as osteoporosis boost the growth of the global internal trauma fixation devices market. The global internal trauma fixation devices market is segmented based on product, material, end user, and region ...
October 2020
261 pages
Endoscopy Devices Market by Product Type (Endoscope, Mechanical Endoscopic Equipment, Visualization & Documentation Systems, Accessories, and Others), Hygiene (Single-use, Reprocessing, and Sterilization), Application (Bronchoscopy, Arthroscopy, Laparoscopy, Urology Endoscopy, Neuroendoscopy, Gastrointestinal Endoscopy, Gynecology Endoscopy, ENT Endoscopy, and Others), and End User (Hospitals, Ambulatory Surgery Centers & Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2027
US$ 6,168.00
The global endoscopy devices market was valued at $31.78 million in 2019, and is projected to reach $43.82 billion by 2027, at a CAGR of 4.1% from 2019 to 2027. Endoscopy is a minimally invasive medic...
October 2020
481 pages
Global Self-Monitoring Blood Glucose Devices Market by Product (Test Strips, Lancets, and Blood Glucose Meters), Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), and End User (Hospitals, Home Settings, and Diagnostic Centers): Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,769.00
The global self-monitoring blood glucose devices market was valued at $8,490.79 million in 2019, and is projected to reach $11,991.98 million by 2027, growing at a CAGR of 4.2% from 2020 to 2027. Diab...
October 2020
249 pages
Implantable Drug Delivery Devices Market by Material (Silicon and Others), Product Type (Implantable Drug Eluting Stents, Implantable Contraceptive Drug Delivery Devices, Implantable Intraocular Drug Delivery Devices, Implantable Brachytherapy Seeds Devices, and Implantable Drug Delivery Pump Devices) and End User (Hospitals, Ambulatory Surgery Center, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2027
US$ 6,168.00
The global implantable drug delivery devices market was valued at $10,091.9 million in 2019, and is projected to reach $13,211.8 million by 2027 at a CAGR of 8.0% from 2020 to 2027. Implantable drug d...
October 2020
219 pages
LATAM Hypoactive Sexual Desire Disorder (HSDD) Treatment Market by Treatment Type (Buspirone, Bupropion, Bremelanotide, and Flibanserin), Sales Channel (Hospitals, Clinics, and Online Retailers): Regional Opportunity Analysis and Industry Forecast, 2020–2027
US$ 4,649.00
The LATAM women hypoactive sexual desire disorder treatment market accounted for $967 million in 2019, and is expected to reach $1,275 million by 2027, registering a CAGR of 6.1% from 2020 to 2027. Hy...
October 2020
150 pages
LATAM Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis, and Other Indications): Regional Opportunity Analysis and Industry Forecast, 2019–2027
US$ 6,168.00
The LATAM pain management drugs market was valued at $2,683.82 million in 2019, and is projected to reach $3,383.20 million by 2027, registering a CAGR of 3.5% from 2020 to 2027. Pain is a distressing...
October 2020
235 pages
Tissue Engineering Market by Type (Synthetic Scaffold Material, Biologically Derived Scaffold Material, and Others), Application (Orthopedics & Musculoskeletal, Neurology, Cardiovascular, Skin & Integumentary, Dental, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
US$ 5,769.00
The global tissue engineering market was valued at $2,374 million in 2019, and is projected to reach $6,815 million by 2027, registering a CAGR of 14.2% from 2020 to 2027. Tissue engineering is an int...
October 2020
227 pages
Head And Neck Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... . The Head And Neck Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Head And Neck Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development ...
October 2020
3419 pages
Gastric Cancer - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Gastric Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gastric Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
2657 pages
Asthma - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
811 pages
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
576 pages
Osteoporosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Osteoporosis (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteoporosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
375 pages
Allergic Rhinitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Allergic Rhinitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
204 pages
Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2020
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Chronic Kidney Disease (Chronic Renal Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
326 pages
Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Idiopathic Pulmonary Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Idiopathic Pulmonary Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
539 pages
Acne Vulgaris - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Acne Vulgaris (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Acne Vulgaris and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
217 pages
Endometriosis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Endometriosis (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Endometriosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
156 pages
Osteoarthritis Pain - Pipeline Review, H2 2020
US$ 2,000.00
... . The Osteoarthritis Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Osteoarthritis Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
233 pages
Premature Ejaculation - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Premature Ejaculation (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Premature Ejaculation and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
42 pages
Cystic Fibrosis - Pipeline Review, H2 2020
US$ 2,500.00
... releases. The Cystic Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
550 pages
Ulcerative Colitis - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Ulcerative Colitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Ulcerative Colitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
779 pages
Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2020
US$ 2,000.00
... . The Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Adrenocortical Carcinoma (Adrenal Cortex Cancer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
204 pages
Oropharyngeal Cancer - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Oropharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Oropharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
724 pages
Chronic Urticaria Or Hives - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Chronic Urticaria Or Hives (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Urticaria Or Hives and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
152 pages
Sickle Cell Disease - Pipeline Review, H2 2020
US$ 2,000.00
... . The Sickle Cell Disease (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sickle Cell Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
October 2020
308 pages
Vitiligo - Pipeline Review, H2 2020
US$ 2,000.00
... releases. The Vitiligo (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Vitiligo and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
October 2020
158 pages
